Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Research Institute (MRI) is a prominent consumer health and nutraceutical company that specializes in the development and commercialization of performance-enhancing supplements. Founded in 1997, the company gained significant industry recognition for pioneering the use of nitric oxide boosters in sports nutrition, most notably through its flagship product NO2. MRI's business model focuses on applying pharmaceutical-style research and marketing to the supplement industry, targeting muscle growth, recovery, and metabolic efficiency. The company has undergone several ownership changes, eventually becoming part of the Nutranext portfolio, which was subsequently acquired by The Clorox Company. Today, MRI continues to operate as a specialized brand within the broader health and wellness sector, focusing on high-performance athletic supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Research Institute.